NCT06753331: A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 25 planned
- Started
- 18 Dec 2024
- Primary completion
- 15 Dec 2030
- Arms
- DSP-1083
- Results
- None posted
- 18 Dec 2024: Trial started
- 31 Dec 2024: Trial registered